BRCA2 and ovarian cancer: It has been observed in multiple individuals with breast and/or ovarian cancer (also denoted BRCA2 9522C>G in the literature) and has been classified pathogenic by ENIGMA-consortium in the ClinVar and BRCA Exchange databases [8].